MX363631B - Composiciones y metodos para tratar infecciones bacterianas. - Google Patents

Composiciones y metodos para tratar infecciones bacterianas.

Info

Publication number
MX363631B
MX363631B MX2015008486A MX2015008486A MX363631B MX 363631 B MX363631 B MX 363631B MX 2015008486 A MX2015008486 A MX 2015008486A MX 2015008486 A MX2015008486 A MX 2015008486A MX 363631 B MX363631 B MX 363631B
Authority
MX
Mexico
Prior art keywords
methods
bacterial infections
compositions
treating bacterial
treating
Prior art date
Application number
MX2015008486A
Other languages
English (en)
Other versions
MX2015008486A (es
Inventor
Vithalbhai Patel Mahesh
Keshav Deshpande Prasad
Bhagwat Sachin
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2015008486A publication Critical patent/MX2015008486A/es
Publication of MX363631B publication Critical patent/MX363631B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Molecular Biology (AREA)

Abstract

Se dan a conocer composiciones y métodos para el tratamiento de infecciones bacterianas farmacéuticas.
MX2015008486A 2013-01-14 2014-01-13 Composiciones y metodos para tratar infecciones bacterianas. MX363631B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN117MU2013 2013-01-14
PCT/IB2014/058221 WO2014108872A1 (en) 2013-01-14 2014-01-13 Compositions and methods for treating bacterial infections

Publications (2)

Publication Number Publication Date
MX2015008486A MX2015008486A (es) 2015-09-10
MX363631B true MX363631B (es) 2019-03-29

Family

ID=50336354

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008486A MX363631B (es) 2013-01-14 2014-01-13 Composiciones y metodos para tratar infecciones bacterianas.

Country Status (12)

Country Link
US (4) US9433613B2 (es)
JP (1) JP6480870B2 (es)
KR (1) KR20150089086A (es)
CN (1) CN104884092A (es)
AU (2) AU2014206087A1 (es)
BR (1) BR112015016033A8 (es)
CA (1) CA2890894C (es)
MX (1) MX363631B (es)
RU (1) RU2676482C2 (es)
SG (1) SG11201503661QA (es)
WO (1) WO2014108872A1 (es)
ZA (1) ZA201503474B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015059643A1 (en) * 2013-10-22 2015-04-30 Wockhardt Limited Pharmaceutical compositions comprising antibacterial agents
ES2804500T3 (es) * 2014-01-21 2021-02-08 Wockhardt Bio Ag Composiciones farmacéuticas que comprenden agentes antibacterianos
CN107980000A (zh) * 2014-04-18 2018-05-01 沃克哈特有限公司 包含抗菌剂的药物组合物
CN110062760A (zh) 2016-10-10 2019-07-26 约翰霍普金斯大学 抗d,d-转肽酶和l,d-转肽酶的抗细菌剂
CN107823213A (zh) * 2017-09-16 2018-03-23 安徽华澳生物技术有限公司 一种肉猪抗生素药物
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CA3110111A1 (en) 2018-08-09 2020-02-13 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
PL1755661T3 (pl) * 2004-05-12 2014-10-31 Brigham & Womens Hospital Inc Gelsolina do stosowania w leczeniu infekcji
CN101039668A (zh) * 2004-08-13 2007-09-19 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂
US20090275552A1 (en) 2006-04-28 2009-11-05 Mahesh Vithalbhai Patel Therapy for Treating Resistant Bacterial Infections
JP5666743B2 (ja) 2011-08-27 2015-02-12 ウォックハート リミテッド １，６−ジアザビシクロ［３，２，１］オクタン−７−オン誘導体および細菌感染の処置におけるそれらの使用
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors

Also Published As

Publication number Publication date
JP6480870B2 (ja) 2019-03-13
CN104884092A (zh) 2015-09-02
US20170172994A1 (en) 2017-06-22
AU2017203932B2 (en) 2019-02-14
CA2890894C (en) 2019-06-11
JP2016504411A (ja) 2016-02-12
RU2676482C2 (ru) 2018-12-29
US20160045480A1 (en) 2016-02-18
US20180263969A1 (en) 2018-09-20
RU2015134149A (ru) 2017-02-16
US9636331B2 (en) 2017-05-02
WO2014108872A1 (en) 2014-07-17
US9433613B2 (en) 2016-09-06
KR20150089086A (ko) 2015-08-04
ZA201503474B (en) 2016-11-30
SG11201503661QA (en) 2015-06-29
AU2014206087A1 (en) 2015-05-28
AU2017203932A1 (en) 2017-07-06
CA2890894A1 (en) 2014-07-17
US20160199360A1 (en) 2016-07-14
BR112015016033A8 (pt) 2018-01-23
BR112015016033A2 (pt) 2017-07-11
MX2015008486A (es) 2015-09-10

Similar Documents

Publication Publication Date Title
EP3003322A4 (en) Compounds and methods for treating bacterial infections
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
PT2986304T (pt) Composição farmacêutica, métodos para o tratamento e suas utilizações
SG11201700621XA (en) Antibiotic compositions for treating bacterial infections
DK2948461T3 (en) Compounds and methods for treating bacterial infections
MX2020004205A (es) Composiciones antibioticas de ceftolozano.
MX2015008486A (es) Composiciones y metodos para tratar infecciones bacterianas.
EP3268010A4 (en) Compositions and methods for treating bacterial infection
ZA201507241B (en) Mannose derivatives for treating bacterial infections
PH12017500602A1 (en) Methods for treating ocular conditions
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
MX2015013021A (es) 5-bromo-indirrubinas.
ZA201608607B (en) Novel fluoroquinolones and use thereof to treat bacterial infections
IN2013MU03216A (es)
EP3212183A4 (en) Synergistic compositions for treating microbial infections
GB2558090B (en) Prevention and treatment for microbial infections
EP3116540A4 (en) Compositions and methods for treating, including preventing, parvovirus infections and related diseases
PT3160263T (pt) Composições para prevenção de infeções
EP3038615A4 (en) Methods for treating bacterial infections using oritavancin and polymyxins
EP3242664A4 (en) Compositions and methods for treating gastrointestinal infections
EP3258958A4 (en) Compositions and methods for preventing and treating rhinovirus infections
IN2013DE03375A (es)
AU2013901517A0 (en) Methods of Treating Bacterial Infections
HK1261426A1 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
MY180947A (en) Ceftolozane antibiotic compositions